| |
|
|
|
9 Meters Biopharma Inc.  
|
|
0 (0%) |
|
|
Open: |
|
Pre close: |
|
Target:
|
0.74 
|
|
High: |
|
Low: |
|
Resistance:
|
0.63
0.69
|
|
Volume: |
|
Market Cap: |
0M |
Support:
|
0.54
0.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.60
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
0.60 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
0.59 |
Stochastic Oscillator |
%K(14,3):
|
35.64 |
|
MA(250): |
0.77 |
%D(3): |
36.90 |
|
Average Volume(K) |
3-Month: |
39488
|
52-Week |
High:
|
1.29 |
|
10-Days: |
41527 |
Low: |
0.37 |
|
RSI |
RSI(14):
|
49.59 |
Change(%): |
-51.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.712 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
41.33 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-193.2 |
Shares Float (M) |
63.88 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.24 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
2.73 |
|
Forward EPS |
-0.810 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
-0.300 |
EBITDA (p.s.) |
-0.593 |
P/E |
-0.83 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.98 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.36 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-7.60 |
P/CF |
-1.50 |
|
|
|
|
|
|
